Evidence map›Paper›PMID 40646449›Full record

ArticleBMC medical imaging2025

The clinical benefits of [

Donghe Chen, Zhenfeng Liu, Guolin Wang, Mengjiao Tu, Fei Yang, Chunting Jiang, Kui Zhao, Xinhui Su

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Donghe ChenDepartment of Nuclear Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China.
Zhenfeng LiuDepartment of Nuclear Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China.
Guolin WangDepartment of Nuclear Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China.
Mengjiao TuDepartment of Nuclear Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China.
Fei YangDepartment of Nuclear Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China.
Chunting JiangDepartment of Nuclear Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China.
Kui ZhaoDepartment of Nuclear Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China. zhaokui0905@zju.edu.cn.
Xinhui SuDepartment of Nuclear Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China. suxinhui@zju.edu.cn.

Funding

Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China LHDMZ22H300010Major plan of Jointly Constructed project by the Science and Technology Department of the State Administration of Traditional Chinese Medicine and the Zhejiang Provincial Administration of Traditional Chinese Medicine GZY-ZJ-KJ-24025National Natural Science Foundation of China 82071965
6 · The paper itself

Abstract

backgroundAccurate clinical TNM staging is crucial for managing GEP-NENs according to the latest NCCN guidelines. [ PURPOSE: This retrospective study compared the performance of [

methodsParticipants with clinically suspected or confirmed NENs were enrolled and underwent paired [

resultsThirty-seven patients and 209 suspicious lesions were included in the statistical analysis. In patients for initial staging (n = 19), [

conclusions[ CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

Heterocyclic Compounds, 1-RingIntestinal NeoplasmsNeuroendocrine TumorsOctreotidePancreatic NeoplasmsPositron Emission Tomography Computed TomographyStomach NeoplasmsAdultAgedFemaleFluorodeoxyglucose F18HumansMaleMiddle AgedNeoplasm StagingRadiopharmaceuticalsFluorodeoxyglucose F18Heterocyclic Compounds, 1-RingOctreotideRadiopharmaceuticals[18F]FDG[18F]OCGEP-NENsNeuroendocrine neoplasmsPET/CTSUVmaxTBR

Identifiers

PMID40646449
PMCPMC12255054

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.